Concomitant use of anxiolytics and medicinal plants: Is there a risk?
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/30219 |
Resumo: | Introduction: There is an increasing use of medicinal herbs in many countries. The positive point of Brazil is its great plant diversity, which provides many lines of treatment with a variety of herbs. A possible integration of the unifying practice in the Unified Health System (SUS) was discussed together with the Ministry of Health, which in turn aims at rational use. Benzodiazepines belong to the group of anxiolytics and hypnotics widely applied by the population. Its use along with certain herbal medicines may interfere with the patient's pharmacotherapy. Objective: Consists of collecting 252 volunteers and identifying patients who use benzodiazepines combined with the use of herbal medicines. The herbal medicines presented will be Hypericum perforatum (St. John's Wort) and Passiflora incarnata (Passion flower or passion fruit). Methodology: The work is a cross-sectional observational study, carried out by digital means with the application of a questionnaire disseminated through social networks. Discussion and Results: 67.1% of the volunteers answered yes to the use of medication continuously, 19.8% answered yes to the use of anxiolytics, 24% for Clonazepam (Rivotril®), 12% for Alprazolam (Front®) , 10% for Diazepam (Valium®), 2% for Bromazepam (Lexotan®), Lorazepam (Lorax®), Midazolam (Dormonid®). 82.4% of the volunteers answered that they had already read the package insert of the medication they were using. Regarding herbal medicines, 52.9% answered that they were not adept at using them, 70.6% answered that they had already heard about drug interactions and 88.2% answered yes to the question related to a herbal medicine being less aggressive in relation to other medicines. When asked about the science of drug interactions with herbal medicines, 58.8% answered no. Conclusion: The main herbal remedies used to treat sleep disorders need attention, as they can have dangerous consequences for patients if used concomitantly with other drugs, promoting the rationalization of their use is necessary. |
id |
UNIFEI_85ea4ab92d2df79fb993a281c91b2819 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/30219 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Concomitant use of anxiolytics and medicinal plants: Is there a risk?Uso concomitante de ansiolíticos plantas medicinales: ¿Hay algún riesgo?Uso concomitante de ansiolíticos e plantas medicinais: Será que há risco?AnxiolyticsHypnoticsConcomitantHerbal medicinesPharmaceutical careDrug interactionBenzodiazepines.AnsioliticosHipnoticosFitoterapicosAtenção FarmaceuticaInteração medicamentosaConcomitanteBenzodiazepínicos.AnsiolíticosHipnóticosConcomitanteMedicamentos a base de plantasAtención farmacéuticaInteracción medicamentosaBenzodiazepinas.Introduction: There is an increasing use of medicinal herbs in many countries. The positive point of Brazil is its great plant diversity, which provides many lines of treatment with a variety of herbs. A possible integration of the unifying practice in the Unified Health System (SUS) was discussed together with the Ministry of Health, which in turn aims at rational use. Benzodiazepines belong to the group of anxiolytics and hypnotics widely applied by the population. Its use along with certain herbal medicines may interfere with the patient's pharmacotherapy. Objective: Consists of collecting 252 volunteers and identifying patients who use benzodiazepines combined with the use of herbal medicines. The herbal medicines presented will be Hypericum perforatum (St. John's Wort) and Passiflora incarnata (Passion flower or passion fruit). Methodology: The work is a cross-sectional observational study, carried out by digital means with the application of a questionnaire disseminated through social networks. Discussion and Results: 67.1% of the volunteers answered yes to the use of medication continuously, 19.8% answered yes to the use of anxiolytics, 24% for Clonazepam (Rivotril®), 12% for Alprazolam (Front®) , 10% for Diazepam (Valium®), 2% for Bromazepam (Lexotan®), Lorazepam (Lorax®), Midazolam (Dormonid®). 82.4% of the volunteers answered that they had already read the package insert of the medication they were using. Regarding herbal medicines, 52.9% answered that they were not adept at using them, 70.6% answered that they had already heard about drug interactions and 88.2% answered yes to the question related to a herbal medicine being less aggressive in relation to other medicines. When asked about the science of drug interactions with herbal medicines, 58.8% answered no. Conclusion: The main herbal remedies used to treat sleep disorders need attention, as they can have dangerous consequences for patients if used concomitantly with other drugs, promoting the rationalization of their use is necessary.Introducción: Hay un uso creciente de hierbas medicinales en muchos países. El punto positivo de Brasil es su gran diversidad vegetal, que brinda muchas líneas de tratamiento con variedad de hierbas. Una posible integración de la práctica unificadora en el Sistema Único de Salud (SUS) fue discutida junto con el Ministerio de Salud, que a su vez tiene como objetivo el uso racional. Las benzodiazepinas pertenecen al grupo de ansiolíticos e hipnóticos de amplia aplicación en la población. Su uso junto con ciertos medicamentos a base de hierbas puede interferir con la farmacoterapia del paciente. Objetivo: Consiste en recolectar 252 voluntarios e identificar a los pacientes que usan benzodiazepinas combinadas con el uso de fitoterápicos. Los medicamentos a base de plantas presentados serán Hypericum perforatum (Hierba de San Juan) y Passiflora incarnata (Pasiflora o maracuyá). Metodología: El trabajo es un estudio observacional transversal, realizado por medios digitales con la aplicación de un cuestionario difundido a través de redes sociales. Discusión y Resultados: El 67,1% de los voluntarios respondieron afirmativamente al uso de medicación continua, el 19,8% respondieron afirmativamente al uso de ansiolíticos, el 24% para Clonazepam (Rivotril), el 12% para Alprazolam (Frente), el 10% para Diazepam (Valium ), 2% para bromazepam (Lexotan), lorazepam (Lorax), midazolam (Dormonid). El 82,4% de los voluntarios respondieron que ya habían leído el prospecto del medicamento que estaban usando. En cuanto a los medicamentos a base de plantas, el 52,9% respondió que no eran expertos en su uso, el 70,6% respondió que ya había oído hablar de las interacciones medicamentosas y el 88,2% respondió que sí a la pregunta relacionada con que un medicamento a base de plantas es menos agresivo en relación con otros medicamentos. Cuando se les preguntó acerca de la ciencia de las interacciones de los medicamentos con las hierbas medicinales, el 58,8% respondió que no. Conclusión: Los principales remedios a base de hierbas utilizados para tratar los trastornos del sueño necesitan atención, ya que pueden tener consecuencias peligrosas para los pacientes si se usan concomitantemente con otras drogas, es necesario promover la racionalización de su uso.Introdução: É crescente de ervas medicinais em muitos países. O ponto positivo do Brasil é sua grande diversidade vegetal, que proporciona muitas linhas de tratamento com uma variedade de ervas. Uma possível integração da prática unificadora no Sistema Único de Saúde (SUS) foi discutida em conjunto com o Ministério da Saúde, que por sua vez visa o uso racional. Os benzodiazepínicos pertencem ao grupo de ansiolíticos e hipnóticos amplamente aplicados pela população. Seu uso junto com certos medicamentos fitoterápicos pode interferir na farmacoterapia do paciente. Objetivo: Consiste na coleta de 252 voluntários e identificação de pacientes que façam uso de benzodiazepínicos combinado a utilização de fitoterápicos. Os Fitoterápicos apresentados serão Hypericum perforatum (Erva de São João) e Passiflora incarnata (Flor da paixão ou maracujá). Metodologia: O trabalho é um estudo observacional do tipo transversal, realizado por meio digital com a aplicação de um questionário divulgado através das redes sociais. Discussão e Resultados: 67,1% dos voluntários responderam sim para o uso de medicamentos de forma contínua, 19,8% responderam sim para o uso de ansiolíticos, sendo eles 24% para Clonazepam (Rivotril®), 12% para Alprazolam (Frontal®), 10% para Diazepam (Valium®), 2% para Bromazepam (Lexotan®), Lorazepam (Lorax®), Midazolam (Dormonid®). 82,4% dos voluntários responderam que já haviam lido a bula do medicamento a qual usavam. Sobre fitoterápicos, 52,9% responderam que não eram adeptos ao uso, 70,6% responderam que já haviam ouvido falar em interações medicamentosas e 88,2% responderam sim para a pergunta relacionada à um fitoterápico ser menos agressivo em relação a outros medicamentos. Quando questionados sobre a ciência de interações medicamentosas com fitoterápicos, 58,8% responderam não. Conclusão: Os principais remédios fitoterápicos usados para tratar distúrbios do sono necessitam de atenção, pois podem ter consequências perigosas para os pacientes se usados concomitantes com outros fármacos, a promoção a racionalização de seu uso faz-se necessária.Research, Society and Development2022-06-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/3021910.33448/rsd-v11i7.30219Research, Society and Development; Vol. 11 No. 7; e59711730219Research, Society and Development; Vol. 11 Núm. 7; e59711730219Research, Society and Development; v. 11 n. 7; e597117302192525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/30219/26201Copyright (c) 2022 Giovana Lima; Tamiris Costa; Alyne Alexandrino Antunes; Rodrigo Vieira Gonzagahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessLima, GiovanaCosta, TamirisAntunes, Alyne AlexandrinoGonzaga, Rodrigo Vieira2022-06-06T15:12:05Zoai:ojs.pkp.sfu.ca:article/30219Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:47:02.915119Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Concomitant use of anxiolytics and medicinal plants: Is there a risk? Uso concomitante de ansiolíticos plantas medicinales: ¿Hay algún riesgo? Uso concomitante de ansiolíticos e plantas medicinais: Será que há risco? |
title |
Concomitant use of anxiolytics and medicinal plants: Is there a risk? |
spellingShingle |
Concomitant use of anxiolytics and medicinal plants: Is there a risk? Lima, Giovana Anxiolytics Hypnotics Concomitant Herbal medicines Pharmaceutical care Drug interaction Benzodiazepines. Ansioliticos Hipnoticos Fitoterapicos Atenção Farmaceutica Interação medicamentosa Concomitante Benzodiazepínicos. Ansiolíticos Hipnóticos Concomitante Medicamentos a base de plantas Atención farmacéutica Interacción medicamentosa Benzodiazepinas. |
title_short |
Concomitant use of anxiolytics and medicinal plants: Is there a risk? |
title_full |
Concomitant use of anxiolytics and medicinal plants: Is there a risk? |
title_fullStr |
Concomitant use of anxiolytics and medicinal plants: Is there a risk? |
title_full_unstemmed |
Concomitant use of anxiolytics and medicinal plants: Is there a risk? |
title_sort |
Concomitant use of anxiolytics and medicinal plants: Is there a risk? |
author |
Lima, Giovana |
author_facet |
Lima, Giovana Costa, Tamiris Antunes, Alyne Alexandrino Gonzaga, Rodrigo Vieira |
author_role |
author |
author2 |
Costa, Tamiris Antunes, Alyne Alexandrino Gonzaga, Rodrigo Vieira |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Lima, Giovana Costa, Tamiris Antunes, Alyne Alexandrino Gonzaga, Rodrigo Vieira |
dc.subject.por.fl_str_mv |
Anxiolytics Hypnotics Concomitant Herbal medicines Pharmaceutical care Drug interaction Benzodiazepines. Ansioliticos Hipnoticos Fitoterapicos Atenção Farmaceutica Interação medicamentosa Concomitante Benzodiazepínicos. Ansiolíticos Hipnóticos Concomitante Medicamentos a base de plantas Atención farmacéutica Interacción medicamentosa Benzodiazepinas. |
topic |
Anxiolytics Hypnotics Concomitant Herbal medicines Pharmaceutical care Drug interaction Benzodiazepines. Ansioliticos Hipnoticos Fitoterapicos Atenção Farmaceutica Interação medicamentosa Concomitante Benzodiazepínicos. Ansiolíticos Hipnóticos Concomitante Medicamentos a base de plantas Atención farmacéutica Interacción medicamentosa Benzodiazepinas. |
description |
Introduction: There is an increasing use of medicinal herbs in many countries. The positive point of Brazil is its great plant diversity, which provides many lines of treatment with a variety of herbs. A possible integration of the unifying practice in the Unified Health System (SUS) was discussed together with the Ministry of Health, which in turn aims at rational use. Benzodiazepines belong to the group of anxiolytics and hypnotics widely applied by the population. Its use along with certain herbal medicines may interfere with the patient's pharmacotherapy. Objective: Consists of collecting 252 volunteers and identifying patients who use benzodiazepines combined with the use of herbal medicines. The herbal medicines presented will be Hypericum perforatum (St. John's Wort) and Passiflora incarnata (Passion flower or passion fruit). Methodology: The work is a cross-sectional observational study, carried out by digital means with the application of a questionnaire disseminated through social networks. Discussion and Results: 67.1% of the volunteers answered yes to the use of medication continuously, 19.8% answered yes to the use of anxiolytics, 24% for Clonazepam (Rivotril®), 12% for Alprazolam (Front®) , 10% for Diazepam (Valium®), 2% for Bromazepam (Lexotan®), Lorazepam (Lorax®), Midazolam (Dormonid®). 82.4% of the volunteers answered that they had already read the package insert of the medication they were using. Regarding herbal medicines, 52.9% answered that they were not adept at using them, 70.6% answered that they had already heard about drug interactions and 88.2% answered yes to the question related to a herbal medicine being less aggressive in relation to other medicines. When asked about the science of drug interactions with herbal medicines, 58.8% answered no. Conclusion: The main herbal remedies used to treat sleep disorders need attention, as they can have dangerous consequences for patients if used concomitantly with other drugs, promoting the rationalization of their use is necessary. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-06-05 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/30219 10.33448/rsd-v11i7.30219 |
url |
https://rsdjournal.org/index.php/rsd/article/view/30219 |
identifier_str_mv |
10.33448/rsd-v11i7.30219 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/30219/26201 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2022 Giovana Lima; Tamiris Costa; Alyne Alexandrino Antunes; Rodrigo Vieira Gonzaga https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2022 Giovana Lima; Tamiris Costa; Alyne Alexandrino Antunes; Rodrigo Vieira Gonzaga https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 11 No. 7; e59711730219 Research, Society and Development; Vol. 11 Núm. 7; e59711730219 Research, Society and Development; v. 11 n. 7; e59711730219 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052713993764864 |